Dr. Claudia Bardoni | Chemo-Immunotherapy | Best Research Award
MD FACS, IEO, Italy
Claudia Bardoni is a thoracic surgeon with extensive experience in thoracic surgery and research. Currently, she works as an Associate Thoracic Surgeon at the European Institute of Oncology (IEO) and is a member of the Nova Talent Network. She has worked in various prestigious institutions, including Università degli Studi di Milano and Cleveland Clinic Abu Dhabi.
Profile
🎓 Education
Although specific educational details are not provided, her experience suggests a strong foundation in medicine and surgery. She has completed fellowships in thoracic surgery, robotics, and microsurgery.
👨🔬 Experience
– Thoracic Surgeon at IEO- Resident Doctor at Università degli Studi di Milano- Clinical Fellow at Cleveland Clinic Abu Dhabi- Surgical Fellow at Klinikum Ernst von Bergmann- Medical Doctor in Covid-19 department
🔍 Research Interest
– Thoracic surgery- Lung transplant- Regenerative medicine- Robotics and microsurgery
🏆Awards and Honors
No specific awards or honors are mentioned, but her membership in the Nova Talent Network, which gathers the top 3% of professionals worldwide, is notable.
📚 Publications
– Evaluation of Methodological Quality of Published Guidelines: Dr. Bardoni co-authored a study evaluating the methodological quality of published guidelines for the surgical treatment of pleural mesothelioma, published in the European Journal of Cancer Prevention in 2023.
– Surgical Management of Superior Sulcus Tumors: She was part of a team that published a 20-year experience of surgical management of superior sulcus tumors at an oncological high-volume referral center in Frontiers in Oncology in 2023.
– Surgical Resection of Pulmonary Metastases: Dr. Bardoni contributed to a multicentric study on surgical resection of pulmonary metastases from melanoma in oligometastatic patients, published in Cancers in 2023.
– Non-Small Cell Lung Cancer: She co-authored a 20-year single-center retrospective study on surgically treated pT2aN0M0 non-small cell lung cancer, published in the Journal of Clinical Medicine in 2023.
– Molecular Biomarkers in Lung Cancer: Dr. Bardoni was involved in a narrative review analyzing molecular biomarkers in resected early-stage non-small cell lung cancer, published in Cancers in 2022.
Some of her other research interests and publications focus on:
– Reducing Postoperative Costs: Dr. Bardoni explored ways to reduce postoperative costs in thoracic surgery, including the use of oral management procedures to prevent complications.
– Body Composition and Complications: She investigated the relationship between CT-derived body composition values and complications after pneumonectomy in lung cancer patients ⁴.
Conclusion
This individual has a strong profile, with prestigious affiliations and editorial roles. While they have a solid foundation in research and clinical practice, more emphasis on publishing research findings, securing funding, and international collaborations would strengthen their application for the Best Researcher Award. With some additional focus on showcasing research achievements, they could demonstrate their suitability for the award.